Minorities Hit Harder By Breast Cancer Costs

Share this content:
Minorities Hit Harder By Breast Cancer Costs
Minorities Hit Harder By Breast Cancer Costs

(HealthDay News) — Racial and ethnic minority patients seem to be more vulnerable to breast cancer-related privations and financial decline, according to a study published online March 24 in the Journal of Clinical Oncology.

Reshma Jagsi, MD, from the University of Michigan in Ann Arbor, and colleagues examined the financial experiences of a racially and ethnically diverse cohort of women diagnosed with nonmetastatic breast cancer from 2005 to 2007. Surveys were conducted about 9 months after diagnosis and 4 years later among 1,502 women.

RELATED: Breast Cancer Resource Center

The researchers found that the median out-of-pocket expenses were ≤$2,000, with 17% reporting spending >$5,000.

At 4 years after diagnosis, 12% of respondents reported medical debt, with significant variation by race: 9% for whites; 15% for blacks; 17% for English-speaking Latinas; and 10% for Spanish-speaking Latinas (P = 0.03).

One-quarter of women experienced financial decline that was at least partly due to breast cancer, with increased odds of decline for Spanish-speaking Latinas versus whites (odds ratio [OR], 2.76; P = 0.006). Eighteen percent of the sample reported at least one privation, with privation significantly more likely for blacks (OR, 2.6; P < 0.001) and English-speaking Latinas (OR, 2.2; P = 0.02) versus whites.

"Racial and ethnic minority patients appear most vulnerable to privations and financial decline attributable to breast cancer, even after adjustment for income, education, and employment," the researchers wrote.


  1. Jagsi R, Pottow JAE, Griffith KA, et al. Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries. J Clin Oncol. 2014; doi:10.1200/JCO.2013.53.0956.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs